NASDAQ: PDEXPro Dex Inc Stock
$32.62-0.45 (-1.36%)
Updated Sep 15, 2025
PDEX Price
$32.62
Fair Value Price
N/A
Market Cap
$106.41M
52 Week Low
$23.68
52 Week High
$70.26
P/E
11.95x
P/B
2.9x
P/S
2.16x
PEG
N/A
Dividend Yield
N/A
Revenue
$66.59M
Earnings
$8.98M
Gross Margin
29.3%
Operating Margin
19.35%
Profit Margin
13.5%
Debt to Equity
0.67
Operating Cash Flow
-$2M
Beta
0.56
Next Earnings
Oct 30, 2025
Ex-Dividend
N/A
Next Dividend
N/A
PDEX Overview
Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine PDEX's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
D
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical
Industry Rating
B
PDEX
Ranked#35 of 43
Ranked#35 of 43
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $15.08 | A | |
| $10.16 | A | |
| $82.93 | B |
Be the first to know about important PDEX news, forecast changes, insider trades & much more!
PDEX News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PDEX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PDEX is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PDEX is good value based on its earnings relative to its share price (11.95x), compared to the US market average (37.32x)
P/E vs Market Valuation
PDEX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more PDEX due diligence checks available for Premium users.
Valuation
PDEX fair value
Fair Value of PDEX stock based on Discounted Cash Flow (DCF)
Price
$32.62
Fair Value
$8.77
Overvalued by
271.99%
PDEX is forecast by analysts... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
PDEX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
11.95x
Industry
30x
Market
37.32x
PDEX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PDEX is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
PDEX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.9x
Industry
3.29x
PDEX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
PDEX's financial health
Profit margin
Revenue
$17.5M
Net Income
$1.2M
Profit Margin
6.8%
PDEX's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
PDEX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$61.2M
Liabilities
$24.6M
Debt to equity
0.67
PDEX's short-term assets ($47.30M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PDEX's short-term assets ($47.30M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PDEX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
PDEX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$173.0k
Investing
-$992.0k
Financing
-$2.9M
PDEX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
PDEX vs Medical Stocks
Pro Dex Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.